...Jie Chen; Suna Fu; Jianhong Yu; Qi Tang; Xiuping Wu; Sai Luo; Huifang Sun Introduction: The aim of this study was to investigate the association of pre-treatment-modified Glasgow Prognostic Score (mGPS) with survival-related outcomes in patients with bladder cancer (BC) and prostate cancer (PC...

... are conflicting. Based on this situation, we conducted a meta-analysis to report the rate of clinically significant prostate cancer (csPCa) on repeat biopsy after a diagnosis of ASAP to determine the safety and validity of deferring repeat biopsy. Methods: We searched PubMed, Medline, Web of Science, and Embase...

... or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2023 Prostate cancer...

...Yura Jotatsu; Katsumi Shigemura; Jack L. Arbiser; Michika Moriwaki; Yuto Hirata; Koki Maeda; Young-min Yang; Masato Fujisawa Introduction: Prostate cancer (PCA) is one of the most common cancers in the world, and current therapies are debilitating to patients. To develop a novel modality...

...Vérane Achard; Cédric Michael Panje; Daniel Engeler; Thomas Zilli; Paul Martin Putora Background: There are many treatment options for localized and locally advanced prostate cancer with radiotherapy and surgery representing the main local therapeutic strategies. Summary: Depending on the risk...

... with a lifetime history of prostate cancer are higher compared to men without a lifetime history of prostate cancer. Here we extend previous findings and examine the role of socioeconomic status in the relationship between depression and cancer survivorship status in a population-based sample of men from Atlantic...

... tumor cells of castration-resistant prostate cancer (PC) patients and its expression correlated with resistance to new-generation androgen signaling inhibitors. Objectives: We retrospectively analyzed whether AR-V7 expression was detectable on radical prostatectomy (RP) specimens of untreated...

... characteristics of coronavirus disease 19 (COVID-19)-infected urologic cancer patients are unknown. Methods: We have analyzed all patients with prostate cancer undergoing hormonal or chemotherapy treatment and receiving telephone and in person pre-triage between March 1 and 27, 2020, at the Tortora Hospital...

...Peter V. Glybochko; Alexander V. Amosov; German E. Krupinov; Nikolay V. Petrovskii; Ilya S. Lumpov Prostate cancer (PrC) is one of the most common tumors diagnosed in men. The detection rate of localized PrC has been dramatically enhanced by screening and the development of visualization methods...

... beam radiation therapy (EBRT) for nonmetastatic prostate cancer. Methods: A sample of 47 men with prostate cancer scheduled to receive radiotherapy (RT) were followed at baseline and 1 year after RT. Clinical and demographic data were obtained from chart review. Symptom measurements included urinary...

... therapy (EBRT) in men with localized prostate cancer. Methods: A total of 36 participants were enrolled and followed up at baseline, 24 h, 7 days, 14 days after EBRT initiation, at midpoint, and at completion of EBRT. Fatigue was measured by self-report using the Functional Assessment of Cancer Therapy...

...Rossella De Luca; Renato Patrizio Costa; Vincenzo Tripoli; Alessandra Murabito; Giuseppe Cicero Background/Aim: Prostate cancer frequently causes bone metastases and skeletal events that impair quality of life (QoL) and survival. The alpha emitter radium-223 is a new drug that improves treatment...

...Rafael Silverman; Kerstie Johnson; Christina Perry; Santhanam Sundar Background: Studies have shown that rectal distension has a significant impact on treatment failure in patients receiving radical radiotherapy for prostate cancer. A distended rectum contributes to excessive organ movement during...

... the effects of ZOL on levels of CECs and CEPs in localized prostate cancer. Methods: Ten consecutive patients with a histologic diagnosis of low-risk prostate adenocarcinoma were enrolled and received an intravenous infusion of ZOL at baseline (T0), 28 days (T28) and 56 days (T56). Blood samples were...

... to Korean prostate cancer (PC) patients. Methods: A total of 172 patients who underwent curative radical prostatectomy (RP) with or without adjuvant androgen deprivation therapy were asked to complete the Korean version of the EORTC QLQ-C30 and PR25 questionnaires 3 times (before and 3 and 6 months after RP...

... therapy for prostate cancer frequently induces gynecomastia, thus negatively affecting the patients’ compliance to treatment because of physical and psychological discomfort deriving from this condition; gynecomastia can in fact be associated with severe breast pain, and it can modify how patients see...

...Chantelle Wilcox; Allison Kautto; Allison Steigler; James W. Denham Objective: To determine if 6 months of neo-adjuvant androgen deprivation is associated with the long-term risk of cardiac mortality. Methods: In the TROG 96.01 trial, 802 men with locally advanced prostate cancer were randomized...

...Irène Asmane; Jocelyn Céraline; Brigitte Duclos; Lynn Rob; Valère Litique; Philippe Barthélémy; Jean-Pierre Bergerat; Patrick Dufour; Jean-Emmanuel Kurtz Although advanced prostate cancer patients respond very well to front-line androgen deprivation, failure to hormonal therapy most often occurs...

...Mira Barak; Yoel Mecz; Aharon Lurie; Nachman Gruener The percentage of nonglycosylated prostate-specific antigen (PSA) was measured in the serum of 15 prostate cancer patients and 15 patients with benign hyperplasia of the prostate. The larger part of serum PSA in both groups was glycosylated...

... immunodiffusion. These cases were diagnosed as having prostate cancer based on prostate biopsy. After estrogen or anti-androgen therapy, the initially severe deficiency of α 2 M changed toward normal limits. Phytohemagglutinin (PHA)-induced lymphocytes from patients with severe α 2 M deficiency revealed normal...